Movement Alert|STERIS plc Intraday Rise 4.22% in Regular Trading, Jefferies Upgrades Rating to Buy With $305 Target

Market Focus11-14

On November 14, STERIS plc recorded an Intraday Rise of 4.22% in Regular Trading, trading at $264.115 per share, with turnover of $135 million.

The immediate catalyst was a fresh analyst action: Jefferies upgraded STERIS plc to Buy from Hold and set a $305 price target, reinforcing improving sentiment after UBS had also lifted its target to $290 while maintaining a Buy rating.

The upgrade came shortly after the company reported fiscal second-quarter adjusted EPS of $2.94, above the $2.68 consensus, on revenue of $1.59 billion versus expectations of $1.56 billion. Management also raised fiscal adjusted EPS guidance to $11.35-$11.55 from $11.10-$11.30, ahead of the $11.21 market expectation, while keeping projected revenue growth at 7% to 8%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment